Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05119335
Title A Study of NKT2152, a HIF2a Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NiKang Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
UCLA Los Angeles California 90095 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Emory University Atlanta Georgia 30322 United States Details
Indiana University Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
National Cancer Institute Bethesda Maryland 20892-9760 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
University of Oklahoma Oklahoma City Oklahoma 73117 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field